- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22:35 | Alnylam faces DOJ probe over Onpattro marketing | ||
| 20:35 | Exclusive interview: Peter Marks on why full Covid-19 vaccine approvals could be just months away | ||
| 20:35 | Janet Woodcock on if the FDA is getting tougher on drug reviews: 'I don't think so' | ||
| 16:35 | Meet Benchling, the latest unicorn seeking to revolutionize the way scientists do work with the help of the cloud | ||
| 16:35 | Covid-19 roundup: Novavax shakes up leadership with two promotions and departure of CFO; Moderna, Novavax shots added to mix-and-match study in the UK | ||
| 16:35 | Amylyx to move forward with ALS program in Europe, but FDA wants another look; Humacyte adds $50M in debt financing | ||
| 15:35 | The right to vote is fundamental - a letter from biotechnology industry leaders | ||
| 15:35 | Launched by MIT grads, a small startup gets $20M to back a robotics revolution in cell therapy manufacturing | ||
| 14:35 | Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery | ||
| 14:35 | It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq | ||
| 14:35 | Anti-aging biotech upstart plucks a drug from Amgen's discard pile, pivoting from heart failure to muscle conditions | ||
| 14:35 | Former head of FDA's medical and scientific affairs on Covid: 'FDA has never been tested like this' | ||
| 13:35 | Eli Lilly seeds a well-connected China neuro startup with drugs aiming at where Biogen, Voyager missed | ||
| 13:35 | 'Learned a lot last year': After Covid-19 success, Moderna's Stéphane Bancel plans to give rest of pipeline a big push | ||
| 10:35 | After being goaded to sell the company, Alexion's CEO set some ambitious new goals for investors. Then Pascal Soriot came calling | ||
| Di | Moderna says Covid-19 boosters stand a fighting chance against new variants | ||
| Di | Pankaj Bhargava was a central figure in the group fashioning Gilead's oncology strategy. Now he's jumped to the VC side and the next-gen tech game | ||
| Di | Fifth Circuit sides with FTC in major pay-for-delay settlement case | ||
| Di | Opinion: Biden needs to step up and nominate an FDA commissioner | ||
| Di | Tumor-treating electric fields show early promise in NSCLC - boosting both Novocure and its Chinese biotech partner | ||
| Di | Recursion lays out $300M+ goal in IPO terms; Evotec and Bristol Myers team up to spin out German research | ||
| Di | FDA dispenses with in-person requirement for abortion pill access during the pandemic | ||
| Di | Tim Lu's gene-circuit star Senti signs up for a $645M discovery alliance with Roche sub Spark | ||
| Di | Bain doubles down on Tony Coles' quest to get a late-stage Parkinson's drug through to market | ||
| Di | Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
